Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ptc Therapeutics (PTCT)

47.39   0.37 (0.79%) 08-07 14:38
Open: 47.16 Pre. Close: 47.02
High: 50.38 Low: 46.975
Volume: 823,534 Market Cap: 3,208M
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for the treatment of rare disorders. The company offers Translarna (ataluren) and Emflaza (deflazacort) for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. It is developing Translarna, which is in Phase 2 clinical study for the treatment of nonsense mutation aniridia and nonsense mutation Dravet syndrome/CDKL5; and RG7916 and RO7034067 for the treatment of patients with spinal muscular atrophy, as well as PTC596 and PTC299, a small molecule dihydrooratate dehydrogenase (DHODH) inhibitor that inhibits de novo pyrimidine nucleotide synthesis, which is in Phase 1 clinical development stage to treat cancer patients. The company is also developing gene therapy product candidate that include PTC-AADC for the treatment of Aromatic L-amino acid decarboxylase deficiency. It has collaborations with F.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 47.427 - 47.669 47.669 - 47.855
Low: 44.235 - 44.481 44.481 - 44.669
Close: 46.616 - 47.044 47.044 - 47.373

Technical analysis

as of: 2020-08-07 2:29:39 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 61.94     One year: 67.90
Support: Support1: 44.78    Support2: 37.26
Resistance: Resistance1: 53.03    Resistance2: 58.13
Pivot: 48.24
Moving Average: MA(5): 48.50     MA(20): 49.87
MA(100): 48.87     MA(250): 47.02
MACD: MACD(12,26): -1.03     Signal(9): -1.05
Stochastic oscillator: %K(14,3): 29.61     %D(3): 25.38
RSI: RSI(14): 51.49
52-week: High: 59.89  Low: 30.79  Change(%): 8.7
Average Vol(K): 3-Month: 77440  10-Days: 121903

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
PTCT has closed below upper band by 18.1%. Bollinger Bands are 36.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 07 Aug 2020
FDA OKs PTC Therapeutics' spinal muscular atrophy treatment Evrysdi - Seeking Alpha

Fri, 07 Aug 2020
PTC Therapeutics Announces FDA Approval of Evrysdi™ (risdiplam) for the Treatment of Spinal Muscular Atrophy in Adults and Children 2 months and older - PRNewswire

Thu, 06 Aug 2020
Credit Suisse Sticks to Its Hold Rating for PTC Therapeutics (PTCT) - Smarter Analyst

Thu, 06 Aug 2020
PTC Therapeutics' Mary Frances Harmon Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine - PRNewswire

Wed, 05 Aug 2020
PTC Therapeutics (PTCT) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Wed, 05 Aug 2020
PTC Therapeutics (PTCT) Misses Q2 EPS by 148c -

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 66
Shares Float (M) 57
% Held by Insiders 3.21
% Held by Institutions 99.32
Shares Short (K) 5,250
Shares Short P. Month (K) 4,400

Stock Financials

EPS -4.830
EPS Est This Year -2.350
EPS Est Next Year -1.970
Book Value (p.s.) 8.430
Profit Margin -90.83
Operating Margin -73.65
Return on Assets (ttm) -10.5
Return on Equity (ttm) -56.1
Qtrly Rev. Growth 27.4
Gross Profit (p.s.) 0.570
Sales Per Share 4.903
EBITDA (p.s.) -3.088
Qtrly Earnings Growth
Operating Cash Flow (M) -138
Levered Free Cash Flow (M) -90

Stock Valuations

PE Ratio -10.42
PEG Ratio
Price to Book value 5.97
Price to Sales 10.27
Price to Cash Flow -23.97

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.